COVID-19 Update: FDA and TTB Response to Increased Demand for Alcohol-Based Hand Sanitizer Production
Will FDA be forced to implement a drug importation program?
FDA launches temporary “TRIP” program to help HCT/P sponsors gain regulatory clarity
FDA Chief of Staff: OTC reform remains “top priority” for FDA
FDA Doubles Down on MUsT Studies for Sunscreens and Issues Final Guidance on Absorption Studies that Will Likely Be Needed for Continued Marketing
New FDA draft guidance on voluntary recalls highlights importance of recall initiation plans
With the Statutory Deadline Approaching, FDA Issues a Proposed Sunscreens Rule
